Phase II study of pemetrexed plus intermittent erlotinib combination therapy for pretreated advanced non-squamous non-small cell lung cancer with documentation of epidermal growth factor receptor mutation status

Autor: Minami, Seigo, Kijima, Takashi, Hamaguchi, Masanari, Nakatani, Takeshi, Koba, Taro, Takahashi, Ryo, Takeuchi, Yoshiko, Kida, Hiroshi, Nagatomo, Izumi, Yamamoto, Suguru, Tachibana, Isao, Komuta, Kiyoshi, Kawase, Ichiro
Zdroj: In Lung Cancer November 2013 82(2):271-275
Databáze: ScienceDirect